OGT Named by Agilent as the First High-Throughput Microarray Certified Service Provider
News Mar 03, 2010
Following almost two years as an Agilent microarray Certified Service Provider, Oxford Gene Technology (OGT) and Agilent Technologies, Inc. announced that OGT is the first company to be named as a High-Throughput Certified Service Provider (HT CSP) for Agilent microarrays.
This new level of the Agilent certification provides official validation of OGT’s use of Agilent microarrays in a high-throughput environment and reflects OGT’s status as the supplier of choice for large-scale outsourced microarray studies.
The certificate has been awarded following assessment of the high-quality experimental data routinely generated by OGT’s high-throughput analysis service – Genefficiency™. OGT’s facility recently completed a 22,000 sample, array comparative genomic hybridization (aCGH) copy number variation (CNV) study for the Wellcome Trust Case Control Consortium. This was the largest ever CNV study to date, generating almost 2 billion data points to exacting quality requirements, in a short timeframe of only 20 weeks.
The HT CSP Certificate was warmly welcomed by OGT’s CEO, Mike Evans: “This certification is a significant endorsement of OGT capabilities. Importantly, this endorsement is also reflected in our customer recommendations; around 65% of our business comes from word-of-mouth, with close to a 100% referral rate from new and existing customers. And we’re not standing still, as we have made significant investments in personnel, equipment and facilities to maintain our position as the worldwide leader in high quality, high-throughput microarray analysis.”
Chris Grimley, Senior Marketing Director of Agilent Technologies Genomics business said: “Agilent is pleased to offer OGT our first certification for High-Throughput Service Provider. OGT has been very successful integrating Agilent Automation Solution instrumentation and Agilent microarrays for an efficient laboratory workflow. We are confident that customers will benefit from the combination of Agilent products and OGT high-throughput service.”
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Rapid Test Helps with Administering the "Correct" DrugNews
In just three hours, a new rapid test will give information on which available antibiotic is still effective in a concrete case.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018